{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:52:13Z","timestamp":1790787133388,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T00:00:00Z","timestamp":1691020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T00:00:00Z","timestamp":1691020800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007001","name":"Small Business Innovative Research and Small Business Technology Transfer","doi-asserted-by":"publisher","award":["AR074337"],"award-info":[{"award-number":["AR074337"]}],"id":[{"id":"10.13039\/100007001","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Sigvard T. Hansen Jr. Endowed Chair"},{"name":"Zimmer Fracture Biology Professorship"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol Exp"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Heterotopic ossification (HO) is a frequent and debilitating complication of traumatic musculoskeletal injuries and orthopedic procedures. Prophylactic dosing of botulinum toxin type A (BTxA) holds potential as a novel treatment option if accurately distributed throughout soft-tissue volumes where protection is clinically desired. We developed a high-resolution, microcomputed tomography (microCT)-based imaging strategy to assess drug distribution and validated this platform by quantifying distribution achieved via a prototype delivery system <jats:italic>versus<\/jats:italic> a single-bolus injection.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We injected an iodine-containing contrast agent (iodixanol 320 mg I\/mL) into dissected rabbit musculature followed by microCT imaging and analysis. To contrast the performance of distributed <jats:italic>versus<\/jats:italic> bolus injections, a three-dimensional (3D) 64-cm<jats:sup>3<\/jats:sup>-printed soft-tissue holder was developed. A centered 2-cm<jats:sup>3<\/jats:sup> volume of interest (VOI) was targeted with a single-bolus injection or an equal volume distributed injection delivered via a 3D-printed prototype. VOI drug coverage was quantified as a percentage of the VOI volume that was &lt; 1.0 mm from the injected fluid.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The microCT-based approach enabled high-resolution quantification of injection distribution within soft tissue. The distributed dosing prototype provided significantly greater tissue coverage of the targeted VOI (72 \u00b1 3%, mean \u00b1 standard deviation) when compared to an equal volume bolus dose (43 \u00b1 5%, <jats:italic>p<\/jats:italic> = 0.031) while also enhancing the precision of injection targeting.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>A microCT-based imaging technique precisely quantifies drug distribution within a soft-tissue VOI, providing a path to overcome a barrier for clinical translation of prophylactic inhibition of HO by BTxA.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Relevance statement<\/jats:title>\n                <jats:p>This platform will facilitate rapid optimization of injection parameters for clinical devices used to effectively and safely inhibit the formation of heterotopic ossification.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Key points<\/jats:title>\n                <jats:p>\u2022 MicroCT provides high-resolution quantification of soft-tissue drug distribution.<\/jats:p>\n                <jats:p>\u2022 Distributed dosing is required to maximize soft-tissue drug coverage.<\/jats:p>\n                <jats:p>\u2022 Imaging platform will enable rapid screening of 3D-printed drug distribution prototypes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Graphical Abstract<\/jats:title>\n                \n              <\/jats:sec>","DOI":"10.1186\/s41747-023-00355-8","type":"journal-article","created":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T00:02:07Z","timestamp":1691020927000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A microCT-based platform to quantify drug targeting"],"prefix":"10.1186","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3533-8303","authenticated-orcid":false,"given":"Brandon J.","family":"Ausk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam N.","family":"Tucker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Huber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Firoozabadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey M.","family":"Gross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ted S.","family":"Gross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven D.","family":"Bain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,3]]},"reference":[{"key":"355_CR1","doi-asserted-by":"publisher","first-page":"e66","DOI":"10.2106\/JBJS.K.01533","volume":"95","author":"AM Foruria","year":"2013","unstructured":"Foruria AM, Augustin S, Morrey BF, Sanchez-Sotelo J (2013) Heterotopic ossification after surgery for fractures and fracture-dislocations involving the proximal aspect of the radius or ulna. J Bone Joint Surg Am 95:e66. https:\/\/doi.org\/10.2106\/JBJS.K.01533","journal-title":"J Bone Joint Surg Am"},{"key":"355_CR2","doi-asserted-by":"publisher","first-page":"476","DOI":"10.2106\/JBJS.F.00412","volume":"89","author":"BK Potter","year":"2007","unstructured":"Potter BK, Burns TC, Lacap AP, Granville RR, Gajewski DA (2007) Heterotopic ossification following traumatic and combat-related amputations. Prevalence, risk factors, and preliminary results of excision. J Bone Joint Surg Am 89:476\u2013486. https:\/\/doi.org\/10.2106\/JBJS.F.00412","journal-title":"J Bone Joint Surg Am"},{"key":"355_CR3","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1016\/j.arth.2014.04.027","volume":"29","author":"DM Tippets","year":"2014","unstructured":"Tippets DM, Zaryanov AV, Burke WV et al (2014) Incidence of heterotopic ossification in direct anterior total hip arthroplasty: a retrospective radiographic review. J Arthroplasty 29:1835\u20131838. https:\/\/doi.org\/10.1016\/j.arth.2014.04.027","journal-title":"J Arthroplasty"},{"key":"355_CR4","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.arth.2007.03.041","volume":"23","author":"K Kaliyaperumal","year":"2008","unstructured":"Kaliyaperumal K, Sathappan SS, Peng LY (2008) Total hip arthroplasty for ankylosed hip secondary to heterotopic ossification. J Arthroplasty 23:470\u2013475. https:\/\/doi.org\/10.1016\/j.arth.2007.03.041","journal-title":"J Arthroplasty"},{"key":"355_CR5","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s11751-014-0192-0","volume":"9","author":"ES Veltman","year":"2014","unstructured":"Veltman ES, Lindenhovius AL, Kloen P (2014) Improvements in elbow motion after resection of heterotopic bone: a systematic review. Strategies Trauma Limb Reconstr 9:65\u201371. https:\/\/doi.org\/10.1007\/s11751-014-0192-0","journal-title":"Strategies Trauma Limb Reconstr"},{"key":"355_CR6","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1007\/s11999-014-3591-0","volume":"472","author":"D Salazar","year":"2014","unstructured":"Salazar D, Golz A, Israel H, Marra G (2014) Heterotopic ossification of the elbow treated with surgical resection: risk factors, bony ankylosis, and complications. Clin Orthop Relat Res 472:2269\u20132275. https:\/\/doi.org\/10.1007\/s11999-014-3591-0","journal-title":"Clin Orthop Relat Res"},{"key":"355_CR7","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1093\/jhps\/hnx010","volume":"4","author":"JM Redmond","year":"2017","unstructured":"Redmond JM, Keegan MA, Gupta A, Worsham JR, Hammarstedt JE, Domb BG (2017) Outcomes of heterotopic ossification excision following revision hip arthroscopy. J Hip Preserv Surg 4:164\u2013169. https:\/\/doi.org\/10.1093\/jhps\/hnx010","journal-title":"J Hip Preserv Surg"},{"key":"355_CR8","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1016\/j.injury.2014.05.018","volume":"45","author":"XB Wu","year":"2014","unstructured":"Wu XB, Yang MH, Zhu SW et al (2014) Surgical resection of severe heterotopic ossification after open reduction and internal fixation of acetabular fractures: a case series of 18 patients. Injury 45:1604\u20131610. https:\/\/doi.org\/10.1016\/j.injury.2014.05.018","journal-title":"Injury"},{"key":"355_CR9","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1089\/neu.2007.0342","volume":"24","author":"B Chalidis","year":"2007","unstructured":"Chalidis B, Stengel D, Giannoudis PV (2007) Early excision and late excision of heterotopic ossification after traumatic brain injury are equivalent: a systematic review of the literature. J Neurotrauma 24:1675\u20131686. https:\/\/doi.org\/10.1089\/neu.2007.0342","journal-title":"J Neurotrauma"},{"key":"355_CR10","doi-asserted-by":"publisher","first-page":"2814","DOI":"10.1007\/s11999-015-4266-1","volume":"473","author":"GJ Pavey","year":"2015","unstructured":"Pavey GJ, Polfer EM, Nappo KE, Tintle SM, Forsberg JA, Potter BK (2015) What risk factors predict recurrence of heterotopic ossification after excision in combat-related amputations? Clin Orthop Relat Res 473:2814\u20132824. https:\/\/doi.org\/10.1007\/s11999-015-4266-1","journal-title":"Clin Orthop Relat Res"},{"key":"355_CR11","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/j.jse.2015.05.044","volume":"24","author":"S Chen","year":"2015","unstructured":"Chen S, Yu SY, Yan H et al (2015) The time point in surgical excision of heterotopic ossification of post-traumatic stiff elbow: recommendation for early excision followed by early exercise. J Shoulder Elbow Surg 24:1165\u20131171. https:\/\/doi.org\/10.1016\/j.jse.2015.05.044","journal-title":"J Shoulder Elbow Surg"},{"key":"355_CR12","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1097\/BOT.0000000000000049","volume":"28","author":"HC Sagi","year":"2014","unstructured":"Sagi HC, Jordan CJ, Barei DP, Serrano-Riera R, Steverson B (2014) Indomethacin prophylaxis for heterotopic ossification after acetabular fracture surgery increases the risk for nonunion of the posterior wall. J Orthop Trauma 28:377\u2013383. https:\/\/doi.org\/10.1097\/BOT.0000000000000049","journal-title":"J Orthop Trauma"},{"key":"355_CR13","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.radonc.2014.08.025","volume":"113","author":"M Popovic","year":"2014","unstructured":"Popovic M, Agarwal A, Zhang L et al (2014) Radiotherapy for the prophylaxis of heterotopic ossification: a systematic review and meta-analysis of published data. Radiother Oncol 113:10\u201317. https:\/\/doi.org\/10.1016\/j.radonc.2014.08.025","journal-title":"Radiother Oncol"},{"key":"355_CR14","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/1748-717X-7-140","volume":"7","author":"MK Farris","year":"2012","unstructured":"Farris MK, Chowdhry VK, Lemke S, Kilpatrick M, Lacombe M (2012) Osteosarcoma following single fraction radiation prophylaxis for heterotopic ossification. Radiat Oncol 7:140. https:\/\/doi.org\/10.1186\/1748-717X-7-140","journal-title":"Radiat Oncol"},{"key":"355_CR15","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.2106\/JBJS.I.01435","volume":"92","author":"N Hamid","year":"2010","unstructured":"Hamid N, Ashraf N, Bosse MJ et al (2010) Radiation therapy for heterotopic ossification prophylaxis acutely after elbow trauma: a prospective randomized study. J Bone Joint Surg Am 92:2032\u20132038. https:\/\/doi.org\/10.2106\/JBJS.I.01435","journal-title":"J Bone Joint Surg Am"},{"key":"355_CR16","doi-asserted-by":"publisher","first-page":"100625","DOI":"10.1016\/j.adro.2020.11.010","volume":"6","author":"SL Freije","year":"2021","unstructured":"Freije SL, Kushdilian MV, Burney HN, Zang Y, Saito NG (2021) A retrospective analysis of 287 patients undergoing prophylactic radiation therapy for the prevention of heterotopic ossification. Adv Radiat Oncol 6:100625. https:\/\/doi.org\/10.1016\/j.adro.2020.11.010","journal-title":"Adv Radiat Oncol"},{"key":"355_CR17","doi-asserted-by":"publisher","first-page":"e828","DOI":"10.1097\/MD.0000000000000828","volume":"94","author":"SL Kan","year":"2015","unstructured":"Kan SL, Yang B, Ning GZ et al (2015) Nonsteroidal anti-inflammatory drugs as prophylaxis for heterotopic ossification after total hip arthroplasty: a systematic review and meta-analysis. Medicine (Baltimore) 94:e828. https:\/\/doi.org\/10.1097\/MD.0000000000000828","journal-title":"Medicine (Baltimore)"},{"key":"355_CR18","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1302\/0301-620X.88B12.18151","volume":"88","author":"MA Karunakar","year":"2006","unstructured":"Karunakar MA, Sen A, Bosse MJ, Sims SH, Goulet JA, Kellam JF (2006) Indometacin as prophylaxis for heterotopic ossification after the operative treatment of fractures of the acetabulum. J Bone Joint Surg Br 88:1613\u20131617. https:\/\/doi.org\/10.1302\/0301-620X.88B12.18151","journal-title":"J Bone Joint Surg Br"},{"key":"355_CR19","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1302\/0301-620x.79b6.6889","volume":"79b","author":"JM Matta","year":"1997","unstructured":"Matta JM, Siebenrock KA (1997) Does indomethacin reduce heterotopic bone formation after operations for acetabular fractures? A prospective randomised study. J Bone Joint Surg Br 79b:959\u2013963. https:\/\/doi.org\/10.1302\/0301-620x.79b6.6889","journal-title":"J Bone Joint Surg Br"},{"key":"355_CR20","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.jseint.2021.04.004","volume":"5","author":"K Bochat","year":"2021","unstructured":"Bochat K, Mattin AC, Ricciardo BJ (2021) The efficacy of nonsteroidal anti-inflammatories in the prevention of heterotopic ossification following elbow trauma surgery. JSES Int 5:793\u2013796. https:\/\/doi.org\/10.1016\/j.jseint.2021.04.004","journal-title":"JSES Int"},{"key":"355_CR21","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1177\/0363546514526361","volume":"42","author":"JT Beckmann","year":"2014","unstructured":"Beckmann JT, Wylie JD, Kapron AL, Hanson JA, Maak TG, Aoki SK (2014) The effect of NSAID prophylaxis and operative variables on heterotopic ossification after hip arthroscopy. Am J Sports Med 42:1359\u20131364. https:\/\/doi.org\/10.1177\/0363546514526361","journal-title":"Am J Sports Med"},{"key":"355_CR22","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/sj.sc.3101166","volume":"39","author":"K Banovac","year":"2001","unstructured":"Banovac K, Williams JM, Patrick LD, Haniff YM (2001) Prevention of heterotopic ossification after spinal cord injury with indomethacin. Spinal Cord 39:370\u2013374. https:\/\/doi.org\/10.1038\/sj.sc.3101166","journal-title":"Spinal Cord"},{"key":"355_CR23","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1056\/NEJMoa050493","volume":"352","author":"RS Bresalier","year":"2005","unstructured":"Bresalier RS, Sandler RS, Quan H et al (2005) Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N Engl J Med 352:1092\u20131102. https:\/\/doi.org\/10.1056\/NEJMoa050493","journal-title":"N Engl J Med"},{"key":"355_CR24","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1302\/0301-620X.89B4.18845","volume":"89","author":"TN Board","year":"2007","unstructured":"Board TN, Karva A, Board RE, Gambhir AK, Porter ML (2007) The prophylaxis and treatment of heterotopic ossification following lower limb arthroplasty. J Bone Joint Surg Br 89:434\u2013440. https:\/\/doi.org\/10.1302\/0301-620X.89B4.18845","journal-title":"J Bone Joint Surg Br"},{"key":"355_CR25","doi-asserted-by":"publisher","first-page":"139","DOI":"10.5435\/00124635-200405000-00001","volume":"12","author":"LE Dahners","year":"2004","unstructured":"Dahners LE, Mullis BH (2004) Effects of nonsteroidal anti-inflammatory drugs on bone formation and soft-tissue healing. J Am Acad Orthop Surg 12:139\u2013143","journal-title":"J Am Acad Orthop Surg"},{"key":"355_CR26","doi-asserted-by":"publisher","first-page":"2759","DOI":"10.1002\/jcb.23259","volume":"112","author":"L Kan","year":"2011","unstructured":"Kan L, Lounev VY, Pignolo RJ et al (2011) Substance P signaling mediates BMP-dependent heterotopic ossification. J Cell Biochem 112:2759\u20132772. https:\/\/doi.org\/10.1002\/jcb.23259","journal-title":"J Cell Biochem"},{"key":"355_CR27","doi-asserted-by":"publisher","first-page":"2748","DOI":"10.1002\/jcb.23225","volume":"112","author":"E Salisbury","year":"2011","unstructured":"Salisbury E, Rodenberg E, Sonnet C et al (2011) Sensory nerve induced inflammation contributes to heterotopic ossification. J Cell Biochem 112:2748\u20132758. https:\/\/doi.org\/10.1002\/jcb.23225","journal-title":"J Cell Biochem"},{"key":"355_CR28","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1615\/CritRevEukarGeneExpr.v20.i4.30","volume":"20","author":"E Salisbury","year":"2010","unstructured":"Salisbury E, Sonnet C, Heggeness M, Davis AR, Olmsted-Davis E (2010) Heterotopic ossification has some nerve. Crit Rev Eukaryot Gene Expr 20:313\u2013324","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"355_CR29","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.bone.2017.07.016","volume":"109","author":"EL Davis","year":"2018","unstructured":"Davis EL, Davis AR, Gugala Z, Olmsted-Davis EA (2018) Is heterotopic ossification getting nervous?: The role of the peripheral nervous system in heterotopic ossification. Bone 109:22\u201327. https:\/\/doi.org\/10.1016\/j.bone.2017.07.016","journal-title":"Bone"},{"key":"355_CR30","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.bone.2011.08.028","volume":"50","author":"BJ Ausk","year":"2012","unstructured":"Ausk BJ, Huber P, Poliachik SL, Bain SD, Srinivasan S, Gross TS (2012) Cortical bone resorption following muscle paralysis is spatially heterogeneous. Bone 50:14\u201322. https:\/\/doi.org\/10.1016\/j.bone.2011.08.028","journal-title":"Bone"},{"key":"355_CR31","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.bone.2013.09.009","volume":"57","author":"BJ Ausk","year":"2013","unstructured":"Ausk BJ, Huber P, Srinivasan S et al (2013) Metaphyseal and diaphyseal bone loss in the tibia following transient muscle paralysis are spatiotemporally distinct resorption events. Bone 57:413\u2013422. https:\/\/doi.org\/10.1016\/j.bone.2013.09.009","journal-title":"Bone"},{"key":"355_CR32","doi-asserted-by":"publisher","first-page":"C533","DOI":"10.1152\/ajpcell.00363.2016","volume":"313","author":"BJ Ausk","year":"2017","unstructured":"Ausk BJ, Worton LE, Smigiel KS et al (2017) Muscle paralysis induces bone marrow inflammation and predisposition to formation of giant osteoclasts. Am J Physiol Cell Physiol 313:C533\u2013C540. https:\/\/doi.org\/10.1152\/ajpcell.00363.2016","journal-title":"Am J Physiol Cell Physiol"},{"key":"355_CR33","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.1007\/s11999-015-4271-4","volume":"473","author":"BJ Ausk","year":"2015","unstructured":"Ausk BJ, Gross TS, Bain SD (2015) Botulinum toxin-induced muscle paralysis inhibits heterotopic bone formation. Clin Orthop Relat Res 473:2825\u20132830. https:\/\/doi.org\/10.1007\/s11999-015-4271-4","journal-title":"Clin Orthop Relat Res"},{"key":"355_CR34","unstructured":"Ausk BJ, Bain SD, Gross TS (2020) Methods for inhibiting heterotopic ossification. UNIV WASHINGTON, US Patent 10,835,689, 17 Nov 2020"},{"key":"355_CR35","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jns.2014.06.028","volume":"344","author":"K Elwischger","year":"2014","unstructured":"Elwischger K, Kasprian G, Weber M et al (2014) Intramuscular distribution of botulinum toxin\u2013visualized by MRI. J Neurol Sci 344:76\u201379. https:\/\/doi.org\/10.1016\/j.jns.2014.06.028","journal-title":"J Neurol Sci"},{"key":"355_CR36","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1002\/jbmr.141","volume":"25","author":"ML Bouxsein","year":"2010","unstructured":"Bouxsein ML, Boyd SK, Christiansen BA, Guldberg RE, Jepsen KJ, Muller R (2010) Guidelines for assessment of bone microstructure in rodents using micro-computed tomography. J Bone Miner Res 25:1468\u20131486. https:\/\/doi.org\/10.1002\/jbmr.141","journal-title":"J Bone Miner Res"},{"key":"355_CR37","doi-asserted-by":"publisher","first-page":"7191","DOI":"10.1088\/0031-9155\/57\/21\/7191","volume":"57","author":"M Thomsen","year":"2012","unstructured":"Thomsen M, Poulsen M, Bech M et al (2012) Visualization of subcutaneous insulin injections by x-ray computed tomography. Phys Med Biol 57:7191\u20137203. https:\/\/doi.org\/10.1088\/0031-9155\/57\/21\/7191","journal-title":"Phys Med Biol"},{"key":"355_CR38","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s12880-021-00689-y","volume":"21","author":"D Steybe","year":"2021","unstructured":"Steybe D, Poxleitner P, Voss PJ et al (2021) Evaluation of computed tomography settings in the context of visualization and discrimination of low dose injections of a novel liquid soft tissue fiducial marker in head and neck imaging. BMC Med Imaging 21:157. https:\/\/doi.org\/10.1186\/s12880-021-00689-y","journal-title":"BMC Med Imaging"},{"key":"355_CR39","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.3389\/fphys.2019.01329","volume":"10","author":"E Nader","year":"2019","unstructured":"Nader E, Skinner S, Romana M et al (2019) Blood rheology: key parameters, impact on blood flow, role in sickle cell disease and effects of exercise. Front Physiol 10:1329. https:\/\/doi.org\/10.3389\/fphys.2019.01329","journal-title":"Front Physiol"},{"key":"355_CR40","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.toxicon.2015.07.013","volume":"107","author":"M Hallett","year":"2015","unstructured":"Hallett M (2015) Explanation of timing of botulinum neurotoxin effects, onset and duration, and clinical ways of influencing them. Toxicon 107:64\u201367. https:\/\/doi.org\/10.1016\/j.toxicon.2015.07.013","journal-title":"Toxicon"},{"key":"355_CR41","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1096\/fj.11-196642","volume":"26","author":"AO Aliprantis","year":"2012","unstructured":"Aliprantis AO, Stolina M, Kostenuik PJ et al (2012) Transient muscle paralysis degrades bone via rapid osteoclastogenesis. FASEB J 26:1110\u20131118. https:\/\/doi.org\/10.1096\/fj.11-196642","journal-title":"FASEB J"},{"key":"355_CR42","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.bone.2005.08.009","volume":"38","author":"SE Warner","year":"2006","unstructured":"Warner SE, Sanford DA, Becker BA, Bain SD, Srinivasan S, Gross TS (2006) Botox induced muscle paralysis rapidly degrades bone. Bone 38:257\u2013264. https:\/\/doi.org\/10.1016\/j.bone.2005.08.009. (S8756-3282(05)00340-6 [pii])","journal-title":"Bone"}],"container-title":["European Radiology Experimental"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41747-023-00355-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41747-023-00355-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41747-023-00355-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T00:02:35Z","timestamp":1691020955000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurradiolexp.springeropen.com\/articles\/10.1186\/s41747-023-00355-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,3]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["355"],"URL":"https:\/\/doi.org\/10.1186\/s41747-023-00355-8","relation":{},"ISSN":["2509-9280"],"issn-type":[{"value":"2509-9280","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,3]]},"assertion":[{"value":"21 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were performed using protocols and procedures approved by the Institutional Animal Care and Use Committee of the University of Washington.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"BA, JG, TG, and SB are co-founders of the In Situ Therapeutic Solutions Inc. The other authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"38"}}